PLUR
Pluri Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$25.61M
P/E Ratio
—
EPS
$-2.90
Beta
0.75
52W High
$5.96
52W Low
$2.22
50-Day MA
$3.28
200-Day MA
$3.75
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
3.63
PEG Ratio
—
About Pluri Inc.
Pluri Inc. is an innovative biotechnology firm specialized in regenerative medicine and immunotherapy, utilizing its proprietary technology platform to develop advanced cell-based therapies for oncology and degenerative diseases. With a strong focus on addressing significant unmet medical needs, Pluri is building a robust pipeline of therapeutics while establishing strategic collaborations within the industry to enhance patient outcomes. The company's commitment to transforming healthcare solutions positions it as a potential leader in the biotech sector, driving growth and delivering impactful advancements in patient care.
Fundamentals
| Revenue (TTM) | $1.08M |
| Gross Profit (TTM) | 464,000 |
| EBITDA | $-25.52M |
| Operating Margin | -3914.00% |
| Return on Equity | -1022.00% |
| Return on Assets | -51.20% |
| Revenue/Share (TTM) | $0.12 |
| Book Value | $-1.78 |
| Price-to-Book | 306.56 |
| Price-to-Sales (TTM) | 23.74 |
| EV/Revenue | 46.27 |
| EV/EBITDA | -1.28 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -60.90% |
| Shares Outstanding | $10.79M |
| Float | $4.19M |
| % Insiders | 46.56% |
| % Institutions | 12.55% |
Historical Volatility
HV 10-Day
124.24%
HV 20-Day
95.38%
HV 30-Day
82.88%
HV 60-Day
67.47%
HV Rank
59.9%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026